secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0000950170-24-122298
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo Q3 revenue record $9.2M (+81% YoY); FY guidance raised to $30-31M
-----------------------------------------------------------------------

- Record Q3 product revenue $9.2M, +83% YoY; net loss $1.0M ($0.03/sh) vs $2.0M loss year ago.
- Gross margin 75.4%, +670 bps; backlog record 316 units (+71%); 225 MyoPro orders (+44%).
- Raised FY2024 revenue guidance to $30-31M from prior $28-30M; expects Q4 rev $9.5-10.5M.
- Cash $7.0M; expects approaching operating cash flow breakeven in Q4.
- Cost per pipeline add $1,618, down 25%; 1,263 patients in pipeline (+21%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017024122298/0000950170-24-122298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017024122298/myo-20241106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-122298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer